・軽度認知障害(MCI)の患者130人で24週間ビフィズス菌を摂取し続けるグループと、プラセボのグループを比較するRCT。 ・ビフィズス菌群でADAS-Jcogの見当識が改善し、VSRADで測定された脳萎縮が抑制。 J Alzheimers Dis 2022 https://t.co/QaAvWsG4S4
Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2022 – Apr 2025Where it's discussed
-
X / Twitter8 posts
-
News4 articles
-
Bluesky2 posts
-
YouTube2 videos
AI synopsis
What people are saying
Discussions reveal a cautious but curious tone, exemplified by posts asking whether this reference is 'sufficiently interesting' for inclusion and commenting on the study's results, highlighting a moderate interest level. The tone and language, such as questions about relevance and references to specific measurements like ADAS-Jcog, reflect a nuanced engagement with the research's potential impact.
The discussions show mixed reactions, with some posts questioning the relevance and others acknowledging the study's potential benefits.
Most posts express moderate curiosity, often questioning the significance of the findings or their applicability.
Some comments delve into the study's methodology or implications, indicating a moderate level of deep engagement.
There's no clear consensus on the broader impact, with some users pondering its significance and others dismissing its immediate practical value.
Top posts
Most liked on X and Bluesky論文こっち。 https://t.co/0j7m0Klga6
✏️プロバイオティクス(代表格が乳酸菌)の24週間の摂取は、脳萎縮の進行を抑制し、MCI被験者の認知機能障害を予防することが示唆されました❗️腸活は、脳に対しても良い影響を及ぼすということですね
Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial https://t.co/KakNs3nLYy
順天堂大学の研究グループがビフィズス菌MCC1274が高齢者の軽度認知障害者の認知機能を改善する事を示唆。 https://t.co/bTOvIG9zPp
Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial. J Alzheimers Dis 2022 2/5
All mentions
Probiotics and Gut Microbiota for Brain and Overall Health
This video explores how intestinal health influences overall physical and mental well-being, emphasizing the role of gut microbiota in metabolism, immune activity, anti-inflammatory responses, and neurological functions…
Probiotic Effects on Cognitive Function in Alzheimer's Disease
This video explores the impact of probiotic supplementation on cognitive function and metabolic status in patients with Alzheimer's Disease. It details findings from a randomized, double-blind, controlled trial…
Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial - PMC https://t.co/fo4SI1NtHI
Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial. J Alzheimers Dis 2022 2/5
[Biblio au hasard] Trouvez-vous cette référence suffisamment intéressante pour l’intégrer dans notre #veille #bibliographique #gériatrique AgingPapers ? Cc @dr.maeker.fr ? https://pubmed.ncbi.nlm.nih.gov/35570493 1/5
[Biblio au hasard] Trouvez-vous cette référence suffisamment intéressante pour l’intégrer dans notre #veille #bibliographique #gériatrique AgingPapers ? Cc @DrMaeker ? https://t.co/GTwRQhhWJw 1/5
@DrMaeker Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial. J Alzheimers Dis 2022 2/5
・軽度認知障害(MCI)の患者130人で24週間ビフィズス菌を摂取し続けるグループと、プラセボのグループを比較するRCT。 ・ビフィズス菌群でADAS-Jcogの見当識が改善し、VSRADで測定された脳萎縮が抑制。 J Alzheimers Dis 2022 https://t.co/QaAvWsG4S4
順天堂大学の研究グループがビフィズス菌MCC1274が高齢者の軽度認知障害者の認知機能を改善する事を示唆。 https://t.co/bTOvIG9zPp
✏️プロバイオティクス(代表格が乳酸菌)の24週間の摂取は、脳萎縮の進行を抑制し、MCI被験者の認知機能障害を予防することが示唆されました❗️腸活は、脳に対しても良い影響を及ぼすということですね
論文こっち。 https://t.co/0j7m0Klga6
Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial https://t.co/KakNs3nLYy